share_log

Nxu Inc | 8-K: Current report

Nxu Inc | 8-K: Current report

Nxu Inc | 8-K:重大事件
美股SEC公告 ·  2024/10/24 12:34

牛牛AI助理已提取核心訊息

Nxu Inc announced a merger agreement with Verde Bioresins Inc on October 23, 2024, in a transaction valuing Verde at approximately $306.9 million and Nxu at $16.2 million. Upon closing, Verde shareholders will own approximately 95% of the combined company, while Nxu shareholders will retain 5%. The merged entity will be renamed Verde Bioresins Corp and trade under the ticker "VRDE".The merger will be executed through a two-step process, with Verde becoming a wholly-owned subsidiary of Nxu. The transaction requires approval from both companies' shareholders, Nasdaq listing approval, and SEC registration effectiveness. Key changes include board restructuring with six Verde appointees and one Nxu appointee, and management transition to Verde's executive team.The deal includes support agreements from major shareholders, with Verde's controlling stockholder and Nxu's directors holding 19% voting power committing to approve the merger. Lock-up agreements restrict share transfers for 180 days post-closing, with additional restrictions on large transfers for 24 months. The merger is expected to close by March 31, 2025.
Nxu Inc announced a merger agreement with Verde Bioresins Inc on October 23, 2024, in a transaction valuing Verde at approximately $306.9 million and Nxu at $16.2 million. Upon closing, Verde shareholders will own approximately 95% of the combined company, while Nxu shareholders will retain 5%. The merged entity will be renamed Verde Bioresins Corp and trade under the ticker "VRDE".The merger will be executed through a two-step process, with Verde becoming a wholly-owned subsidiary of Nxu. The transaction requires approval from both companies' shareholders, Nasdaq listing approval, and SEC registration effectiveness. Key changes include board restructuring with six Verde appointees and one Nxu appointee, and management transition to Verde's executive team.The deal includes support agreements from major shareholders, with Verde's controlling stockholder and Nxu's directors holding 19% voting power committing to approve the merger. Lock-up agreements restrict share transfers for 180 days post-closing, with additional restrictions on large transfers for 24 months. The merger is expected to close by March 31, 2025.
Nxu Inc於2024年10月23日宣佈與Verde Bioresins Inc達成合並協議,此交易使Verde的估值約爲30690萬美元,Nxu的估值爲1620萬美元。合併完成後,Verde的股東將擁有合併後公司的約95%股份,而Nxu的股東將保留5%。合併後的實體將更名爲Verde Bioresins CORP,並在交易代碼"VRDE"下交易。合併將通過兩步流程執行,Verde將成爲Nxu的全資子公司。該交易需要兩家公司股東的批准、納斯達克上市批准以及SEC註冊生效。主要變更包括董事會重組,六名Verde指定的董事與一名Nxu指定的董事,以及管理層向Verde的執行團隊過渡。該協議包括主要股東的支持協議,Verde的控股股東和Nxu的董事持有19%的投票權,承諾批准合併。禁售協議限制了合併後180天內的股份轉讓,對於大額轉讓還有24個月的額外限制。合併預計將在2025年3月31日之前完成。
Nxu Inc於2024年10月23日宣佈與Verde Bioresins Inc達成合並協議,此交易使Verde的估值約爲30690萬美元,Nxu的估值爲1620萬美元。合併完成後,Verde的股東將擁有合併後公司的約95%股份,而Nxu的股東將保留5%。合併後的實體將更名爲Verde Bioresins CORP,並在交易代碼"VRDE"下交易。合併將通過兩步流程執行,Verde將成爲Nxu的全資子公司。該交易需要兩家公司股東的批准、納斯達克上市批准以及SEC註冊生效。主要變更包括董事會重組,六名Verde指定的董事與一名Nxu指定的董事,以及管理層向Verde的執行團隊過渡。該協議包括主要股東的支持協議,Verde的控股股東和Nxu的董事持有19%的投票權,承諾批准合併。禁售協議限制了合併後180天內的股份轉讓,對於大額轉讓還有24個月的額外限制。合併預計將在2025年3月31日之前完成。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 2205

熱點推薦

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。